Publications by authors named "Ivan Ilin"

Claim this Profile
C
Chemical Adjustment of Fibrinolysis.
Alexey M Shibeko, Ivan S Ilin, Nadezhda A Podoplelova, Vladimir B Sulimov, Mikhail A Panteleev

Pharmaceuticals (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, Synthesis, and Evaluation of New Hybrid Derivatives of 5,6-Dihydro-4-pyrrolo[3,2,1-]quinolin-2(1)-one as Potential Dual Inhibitors of Blood Coagulation Factors Xa and XIa.
Anna A Skoptsova, Athina Geronikaki, Nadezhda P Novichikhina, Alexey V Sulimov, Ivan S Ilin

Molecules· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Hybrid Tetrahydropyrrolo[3,2,1-]quinolin-1-ylidene-2-thioxothiazolidin-4-ones as New Inhibitors of Factor Xa and Factor XIa: Design, Synthesis, and In Silico and Experimental Evaluation.
Nadezhda P Novichikhina, Alexander S Shestakov, Svetlana M Medvedeva, Anna M Lagutina, Mikhail Yu Krysin, Ivan S Ilin

Molecules· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experimentally Validated Novel Factor XIIa Inhibitors Identified by Docking and Quantum Chemical Post-processing.
Ivan Ilin, Nadezhda Podoplelova, Alexey Sulimov, Danil Kutov, Anna Tashchilova

Mol Inform· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Chemicals Suppressing SARS-CoV-2 Replication in Cell Culture.
Alexey Sulimov, Ivan Ilin, Danil Kutov, Khidmet Shikhaliev, Dmitriy Shcherbakov

Molecules· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Inhibitors of 2'--Methyltransferase of the SARS-CoV-2 Coronavirus.
Alexey Sulimov, Danil Kutov, Ivan Ilin, Yibei Xiao, Sheng Jiang

Molecules· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Blood Coagulation Factor XIIa Inhibitors: Molecular Modeling, Synthesis, and Experimental Confirmation.
Anna Tashchilova, Nadezhda Podoplelova, Alexey Sulimov, Danil Kutov, Ivan Ilin

Molecules· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantum-Chemical Quasi-Docking for Molecular Dynamics Calculations.
Alexey Sulimov, Danil Kutov, Ivan Ilin, Vladimir Sulimov

Nanomaterials (Basel)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docking Paradigm in Drug Design.
Vladimir B Sulimov, Danil C Kutov, Anna S Taschilova, Ivan S Ilin, Eugene E Tyrtyshnikov

Curr Top Med Chem· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, Docking, and In Vitro Anticoagulant Activity Assay of Hybrid Derivatives of Pyrrolo[3,2,1-]Quinolin-2(1)-one as New Inhibitors of Factor Xa and Factor XIa.
Nadezhda Novichikhina, Ivan Ilin, Anna Tashchilova, Alexey Sulimov, Danil Kutov

Molecules· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New factor Xa inhibitors based on 1,2,3,4-tetrahydroquinoline developed by molecular modelling.
Ivan Ilin, Elena Lipets, Alexey Sulimov, Danil Kutov, Khidmet Shikhaliev

J Mol Graph Model· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New generation of docking programs: Supercomputer validation of force fields and quantum-chemical methods for docking.
Alexey V Sulimov, Danil C Kutov, Ekaterina V Katkova, Ivan S Ilin, Vladimir B Sulimov

J Mol Graph Model· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis